In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner.

This whitepaper presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value.

In this whitepaper, explore the nuances of valuation, its framework and the processes for getting it right.

This white paper discusses key M&A trends and common reasons why realized value is often lower than expected value during the deal process.

가치 평가는 모든 거래에서 가장 중요한 부분이지만 중요한 만큼 이해가 어려운 분야입니다. 아센토 캐피털의 매니징 파트너인 벤 보이세빈 (Ben Boissevain)과 함께 "가치 평가"라는 단어의 의미, 개요 및 가치 평가를 성공적으로 처리하기 위한 과정을 알아보십시오.

估值是每笔交易中最关键的部分，但它往往是最不被理解的部分。与Ascento Capital的管理合伙人本·博伊塞万（Ben Boissevain）一起探讨估值的细微差别、估值框架以及正确估值的流程。